<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Jost B. Jonas</author>
     <author>Rahul A. Jonas</author>
     <author>Bikbov, M.M.</author>
     <author>Kazakbaeva, G.M.</author>
     <author>Iakupova, E.M.</author>
     <author>Ya Xing Wang</author>
     <author>Vinay Nangia</author>
     <author>Songhomitra Panda-Jonas</author>
    </authors>
   </contributors>
   <titles>
    <title>Differentiation Between Moderate Versus High Myopia: The 2-Continent Eye Study</title>
   </titles>
   <keywords>
    <keyword>high myopia-associated optic neuropathy</keyword>
    <keyword>myopia</keyword>
    <keyword>myopic macular&#13;
degeneration</keyword>
    <keyword>pathologic myopia</keyword>
    <keyword>Scopus</keyword>
    <keyword>Web of Science</keyword>
   </keywords>
   <dates>
    <year>2026</year>
    <pub-dates>
     <date>2026-06-07</date>
    </pub-dates>
   </dates>
   <doi>10.1016/j.xops.2025.100999</doi>
   <journal>OPHTHALMOLOGY SCIENCE</journal>
   <abstract>Objective: To determine the cutoff value in axial length between moderate myopia versus high myopia in&#13;
dependence on the prevalence of myopic macular degeneration (MMD).&#13;
Design: Population-based studies conducted in Russia, China, and India.&#13;
Participants: The project included the population-based investigations of the Beijing Eye Study (n = 3325; age:&#13;
40+ years), Russian Ural Eye and Medical Study (n = 5586 participants; age: 40+ years), Ural Very Old Study (n = 541;&#13;
age: 85+ years) and Ural Children Eye Study (n = 4255; age: 6+ years), and Central India Eye and Medical Study (n =&#13;
4467; age: 30+ years).&#13;
Methods: The participants underwent a series of general medical and ophthalmic examinations, including fundus&#13;
photography and ocular biometry. Myopic macular degeneration was defined according to the Meta-analysis for&#13;
Pathologic Myopia Study Group.&#13;
Main Outcome Measures: Prevalence of MMD in dependence on axial length.&#13;
Results: The total study population included 36 123 eyes (18 471 individuals) (age: 47.4 ± 23.4 years; range: 6—100&#13;
years) (axial length: 23.2 ± 1.1 mm; range: 18.22—34.20 mm). In the total study population, higher MMD stage was&#13;
associated with longer axial length (β: 0.55; B: 0.14; 95% confidence interval [CI]: 0.14—0.15; P &lt; 0.001), older age (β:&#13;
0.09; B: 0.001; 95% CI: 0.001—0.001; P &lt; 0.001), female sex (β: 0.12; B: 0.07; 95% CI: 0.06—0.07; P &lt; 0.001), and Indian&#13;
ethnicity (β: 0.10; B: 0.07; 95% CI: 0.06—0.07; P &lt; 0.001). Higher prevalence of MMD stage 2+ and 3+ correlated with&#13;
longer axial length (odds ratio [OR]: 9.10; 95% CI: 6.93—11.9; P &lt; 0.001 and OR: 6.90; 95% CI: 5.14—9.26; P &lt; 0.001,&#13;
respectively), older age (OR: 1.06; 95% CI: 1.04—1.08; P &lt; 0.001 and OR: 1.08; 95% CI: 1.05—1.11; P &lt; 0.001, respectively),&#13;
and Indian ethnicity (OR: 6.96; 95% CI: 2.70—17.9; P &lt; 0.001 and OR: 3.69; 95% CI: 1.26—10.8; P = 0.02, respectively).&#13;
The turning points of the regression curves of the associations of axial length with prevalence of MMD stage 2+ and 3+&#13;
were located at axial length values of between 26.0 and 26.5 mm, respectively.&#13;
Conclusions: The axial length-related cutoff for moderate versus high myopia was located approximately at 26.0&#13;
and 26.5 mm for the prevalence of MMD stage 2+ and 3+, respectively, with higher values for younger individuals.&#13;
Myopic macular degeneration prevalence was higher in the Indian cohort.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/5494</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/5688</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
